Cytokinetics CEO on shares soaring, heart drug Aficamten and American heart health
0
0
28/12/23
Dans
Amérique du Nord / États-Unis
Robert Blum, Cytokinetics CEO, joins 'The Exchange' to discuss the biotech sector, the company's shares soaring on the latest trial of its heart drug, and more.
Montre plus
0 commentaires
sort Trier par
